相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis
Ying Qing et al.
MOLECULAR CELL (2021)
Therapeutic Potential of microRNA Against Th2-associated Immune Disorders
Sunil Kumar et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2021)
Concurrent inhibition of IDH and methyltransferase maximizes therapeutic efficacy in IDH mutant acute myeloid leukemia
Zhihong Zeng et al.
HAEMATOLOGICA (2021)
Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia
Eliza Yankova et al.
NATURE (2021)
Recent Clinical Update of Acute Myeloid Leukemia: Focus on Epigenetic Therapies
Eunyoung Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2021)
The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function
Christopher Mapperley et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Emerging drug profile: CPX-351 (vyxeos) in AML
Mansour Alfayez et al.
LEUKEMIA & LYMPHOMA (2020)
Decitabine and all-trans retinoic acid synergistically exhibit cytotoxicity against elderly AML patients via miR-34a/MYCN axis
Yang Cao et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia
Chao Shen et al.
CELL STEM CELL (2020)
Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors
Xu Qing-Yu et al.
CHINESE MEDICAL JOURNAL (2020)
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion
Rui Su et al.
CANCER CELL (2020)
Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity
Huang Zhu et al.
CELL STEM CELL (2020)
It's Not What You Say But How You Say It: Targeting RNA Methylation in AML
Sarah Naomi Olsen et al.
MOLECULAR CELL (2020)
The Potential Role of N6-Methyladenosine (m6A) Demethylase Fat Mass and Obesity-Associated Gene (FTO) in Human Cancers
Jin-yan Wang et al.
ONCOTARGETS AND THERAPY (2020)
Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy
Jenna L. Carter et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
New directions for emerging therapies in acute myeloid leukemia: the next chapter
Naval Daver et al.
BLOOD CANCER JOURNAL (2020)
ADAR1: A New Target for Immuno-oncology Therapy
Amruta Bhate et al.
MOLECULAR CELL (2019)
Structural insights into FTO's catalytic mechanism for the demethylation of multiple RNA substrates
Xiao Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Impact of c-MYC expression on proliferation, differentiation, and risk of neoplastic transformation of human mesenchymal stromal cells
Svitlana Melnik et al.
STEM CELL RESEARCH & THERAPY (2019)
Next Generation Sequencing in AML-On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?
Michael Leisch et al.
CANCERS (2019)
Novel monoclonal antibody-based therapies for acute myeloid leukemia
Linde M. Morsink et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2019)
Venetoclax-based therapies for acute myeloid leukemia
Veronica A. Guerra et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2019)
The Yin and Yang of RNA Methylation: An Imbalance of Erasers Enhances Sensitivity to FTO Demethylase Small-Molecule Targeting in Leukemia Stem Cells
Inge Van der Werf et al.
CANCER CELL (2019)
Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia
Yue Huang et al.
CANCER CELL (2019)
Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia
Jasmin Paris et al.
CELL STEM CELL (2019)
Potential Consequences of Regional Species Loss for Global Species Richness: A Quantitative Approach for Estimating Global Extinction Probabilities
Koen J. J. Kuipers et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2019)
Dendritic Cell-Mediated Th2 Immunity and Immune Disorders
Sunil Kumar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/-catenin pathway in acute myeloid leukemia
Bing Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers
Hailing Shi et al.
MOLECULAR CELL (2019)
Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
Danielle Golub et al.
FRONTIERS IN ONCOLOGY (2019)
Histone Deacetylase Inhibition with Panobinostat Combined with Intensive Induction Chemotherapy in Older Patients with Acute Myeloid Leukemia: Phase I Study Results
MatthewJ. Wieduwilt et al.
CLINICAL CANCER RESEARCH (2019)
The new perspectives of targeted therapy in acute myeloid leukemia
Angela Walasek
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2019)
TNF-α Differentially Regulates Cell Cycle Genes in Promyelocytic and Granulocytic HL-60/S4 Cells
Elsie C. Jacobson et al.
G3-GENES GENOMES GENETICS (2019)
DNA methyltransferases: emerging targets for the discovery of inhibitors as potent anticancer drugs
Jie Yu et al.
DRUG DISCOVERY TODAY (2019)
Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications
Xianwen Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia
Daniel J. DeAngelo et al.
LEUKEMIA RESEARCH (2019)
Chemical inhibitors make their RNA epigenetic mark
Megan Cully
NATURE REVIEWS DRUG DISCOVERY (2019)
Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases
Lucia Mundo et al.
BLOOD CANCER JOURNAL (2019)
HDAC Inhibitors in Acute Myeloid Leukemia
Edurne San Jose-Eneriz et al.
CANCERS (2019)
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
Aviva C. Krauss et al.
CLINICAL CANCER RESEARCH (2019)
The success and the challenge of all-trans retinoic acid in the treatment of cancer
Xiaoling Ni et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2019)
Pharmacological Inhibition of the RNA m6a Writer METTL3 As a Novel Therapeutic Strategy for Acute Myeloid Leukemia
Konstantinos Tzelepis et al.
BLOOD (2019)
Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia
Juanjuan Zhao et al.
BIOMARKER RESEARCH (2019)
Overexpression of TACC3 in Breast Cancer Associates With Poor Prognosis
Haiping Song et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2018)
R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling
Rui Su et al.
CELL (2018)
METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification
Hengyou Weng et al.
CELL STEM CELL (2018)
Tet2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation
Qicong Shen et al.
NATURE (2018)
Suppression of m6A reader Ythdf2 promotes hematopoietic stem cell expansion
Zhenrui Li et al.
CELL RESEARCH (2018)
Writer's block: preventing m6A mRNA methylation promotes T cell naivety
Jonathan Sprent et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)
G. Bug et al.
LEUKEMIA (2017)
m6A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways
Hua-Bing Li et al.
NATURE (2017)
Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control
Isaia Barbieri et al.
NATURE (2017)
An epitranscriptomic vulnerability in myeloid malignancies
Alexandra C. Schmiechen et al.
NATURE MEDICINE (2017)
The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells
Ly P. Vu et al.
NATURE MEDICINE (2017)
Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia
H-A Hou et al.
BLOOD CANCER JOURNAL (2017)
m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells
Qi Cui et al.
CELL REPORTS (2017)
Understanding RNA modifications: the promises and technological bottlenecks of the 'epitranscriptome'
Matthias Schaefer et al.
OPEN BIOLOGY (2017)
Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis
Eva M. Putz et al.
ONCOIMMUNOLOGY (2017)
Leukemia-initiating Cells in T-Cell Acute Lymphoblastic Leukemia
Shi Hao Tan et al.
FRONTIERS IN ONCOLOGY (2017)
Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression
Luisa Cimmino et al.
CELL (2017)
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase
Zejuan Li et al.
CANCER CELL (2017)
CIS is a potent checkpoint in NK cell-mediated tumor immunity
Rebecca B. Delconte et al.
NATURE IMMUNOLOGY (2016)
miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathways
Zhi Hong Fang et al.
CELL DEATH & DISEASE (2016)
Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia
Norbert Vey et al.
ONCOTARGET (2016)
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
Konstantinos Tzelepis et al.
CELL REPORTS (2016)
Mutations in AML: prognostic and therapeutic implications
Courtney D. DiNardo et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)
T-cell acute lymphoblastic leukemia
Elizabeth A. Raetz et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)
Important Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic Challenge
Balraj Singh et al.
PLOS ONE (2016)
A Radioactivity-Based Assay for Screening Human m6A-RNA Methyltransferase, METTL3-METTL14 Complex, and Demethylase ALKBH5
Fengling Li et al.
JOURNAL OF BIOMOLECULAR SCREENING (2016)
Vosaroxin and vosaroxin plus low-dose Ara-C (LDAC) vs low-dose Ara-C alone in older patients with acute myeloid leukemia
Mike Dennis et al.
BLOOD (2015)
Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance
Douglas C. Palmer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
BET inhibitor resistance emerges from leukaemia stem cells
Chun Yew Fong et al.
NATURE (2015)
Pathways related to PMA-differentiated THP1 human monocytic leukemia cells revealed by RNA-Seq
Zeng ChengWu et al.
SCIENCE CHINA-LIFE SCIENCES (2015)
TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma
Dong-Sheng Zhou et al.
ONCOTARGET (2015)
Meclofenamic acid selectively inhibits FTO demethylation of m(6)A over ALKBH5
Yue Huang et al.
NUCLEIC ACIDS RESEARCH (2015)
The Demethylase Activity of FTO (Fat Mass and Obesity Associated Protein) Is Required for Preadipocyte Differentiation
Meizi Zhang et al.
PLOS ONE (2015)
Synthesis of a FTO Inhibitor with Anticonvulsant Activity
Guanqun Zheng et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Human acute promyelocytic leukemia NB4 cells are sensitive to esculetin through induction of an apoptotic mechanism
Virginia Rubio et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium Study
Mark H. Kirschbaum et al.
LEUKEMIA & LYMPHOMA (2014)
N6-methyladenosine-dependent regulation of messenger RNA stability
Xiao Wang et al.
NATURE (2014)
Sensitivity of MLL-rearranged AML cells to all-trans retinoic acid is associated with the level of H3K4me2 in the RARα promoter region
K. Sakamoto et al.
BLOOD CANCER JOURNAL (2014)
Exome-based analysis for RNA epigenome sequencing data
Jia Meng et al.
BIOINFORMATICS (2013)
SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
May S. Kung Sutherland et al.
BLOOD (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Regulation of DC development and DC-mediated T-cell immunity via CISH
Mohammad Alam Miah et al.
ONCOIMMUNOLOGY (2013)
Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop Codons
Kate D. Meyer et al.
CELL (2012)
DNA methyltransferase inhibitors in acute myeloid leukemia: discovery, design and first therapeutic experiences
Xavier Thomas
EXPERT OPINION ON DRUG DISCOVERY (2012)
All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia
Riccardo Masetti et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dan Dominissini et al.
NATURE (2012)
N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO (vol 7, pg 885, 2011)
Guifang Jia et al.
NATURE CHEMICAL BIOLOGY (2012)
Targeting Epigenetic Readers in Cancer
Mark A. Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Dendritic cell-based therapeutic vaccination for acute myeloid leukemia
Sebastien Anguille et al.
BULLETIN DU CANCER (2012)
Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia
A. Quintas-Cardama et al.
LEUKEMIA (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells
Kyung-Dal Choi et al.
NATURE PROTOCOLS (2011)
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Maria E. Figueroa et al.
CANCER CELL (2010)
Inhibition of cell differentiation A critical mechanism for MYC-mediated carcinogenesis?
Javier Leon et al.
CELL CYCLE (2009)
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Mamta Tahiliani et al.
SCIENCE (2009)
Acute promyelocytic leukemia: from highly fatal to highly curable
Zhen-Yi Wang et al.
BLOOD (2008)
Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO
Guifang Jia et al.
FEBS LETTERS (2008)
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang et al.
GENOME BIOLOGY (2008)
Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes
Guillermo Garcia-Manero et al.
BLOOD (2008)
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9
Andrei V. Krivtsov et al.
NATURE (2006)
Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways
A Glasow et al.
BLOOD (2005)
Design, synthesis, and biological evaluation of a small-molecule inhibitor of the histone acetyltransferase Gcn5
M Biel et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)
ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells
FC Guibal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
ATRA-regulated Asb-2 gene induced in differentiation of HL-60 leukemia cells
J Kohroki et al.
FEBS LETTERS (2001)
分享论文
